EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

PRECeDe Pilot: Prevention of neonatal respiratory distress with antenatal corticosteroids before elective caesarean section in women with diabetes – a feasibility randomised trial

Joanne M Said iD, Amalia Karahalios, Christopher J Yates, Devaang A Kevat, Rosalynn Pszczola, Lee-Anne Lynch, Elizabeth Korevaar, Klea Atallah, Vidanka Vasilevski, Linda Sweet, Lex W Doyle

BJOG: An International Journal of Obstetrics & Gynaecology · 2023

DOI: 10.1111/1471-0528.17513 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2023. Verfasst von Joanne M Said und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal Fetal Medicine, Joan Kirner Women's & Children's Sunshine Hospital, Western Health, St Albans, Victoria, Australia. Hauptthemen laut MEDLINE: Betamethasone, Cesarean Section, Diabetes, Gestational, Glucocorticoids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Western Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The PRECeDe Pilot Trial was designed to determine the feasibility of undertaking a multicentre, randomised controlled trial (RCT) to assess the efficacy of antenatal corticosteroids administration within 7 days before elective caesarean section (CS) in women with pre‐gestational diabetes (PGDM) or gestational diabetes (GDM).

Design

Triple blind, parallel group, placebo‐controlled, pilot RCT.

Setting

Single‐centre tertiary maternity hospital in Melbourne, Australia. Population Pregnant women with PGDM (type 1 or type 2 diabetes) or GDM booked for a planned CS scheduled between 35 +0 and 38 +6 weeks of gestation.

Methods

Eligible participants were randomised to receive two injections of either betamethasone 11.4 mg or normal saline placebo, 24 hours apart within 7 days before CS scheduled between 35 +0 and 38 +6 weeks of gestation. Main Outcome Measure The proportion of eligible women who consented and were randomised. Trial Registration Australian and New Zealand Clinical Trials Registry ACTRN12619001475134.

Results

Of 537 women eligible, 182 were approached and 47 (26%) were recruited. Of these, 22 were allocated to the betamethasone group and 25 were allocated to the placebo group. There were no serious adverse events related to participation.

Conclusion

It is feasible to undertake a triple‐blind, placebo‐controlled RCT investigating the efficacy of antenatal corticosteroids in preventing respiratory morbidity in infants of women with PGDM or GDM who are undergoing an elective CS between 35 +0 and 38 +6 weeks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BetamethasoneCesarean SectionDiabetes, GestationalGlucocorticoidsPregnancy in DiabeticsRespiratory Distress Syndrome, NewbornAdultFemaleHumansInfant, NewbornPregnancyAdrenal Cortex HormonesElective Surgical ProceduresFeasibility StudiesPilot ProjectsPrenatal Care

Stichwörter der Autor:innen

antenatal corticosteroidsbetamethasonecaesarean sectiondiabetesgestational diabetesneonatal hypoglycaemiarespiratory distress syndrome

Substanzen

Adrenal Cortex HormonesBetamethasoneGlucocorticoids

Autor:innen und Institutionen

  • Department of Maternal Fetal Medicine, Joan Kirner Women's & Children's Sunshine Hospital, Western Health, St Albans, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Endocrinology, Western Health, St Albans, Victoria, Australia.
  • Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
  • Newborn Services, Joan Kirner Women's & Children's Sunshine Hospital, Western Health, St Albans, Victoria, Australia.

ORCID-Profile: Joanne M Said

Förderung

  • Western Health

Zitieren

APA

Said, J. M., Karahalios, A., Yates, C. J., Kevat, D. A., Pszczola, R., Lynch, L. A., Korevaar, E., Atallah, K., Vasilevski, V., Sweet, L., & Doyle, L. W. (2023). PRECeDe Pilot: Prevention of neonatal respiratory distress with antenatal corticosteroids before elective caesarean section in women with diabetes – a feasibility randomised trial. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17513

Vancouver

Said JM, Karahalios A, Yates CJ, Kevat DA, Pszczola R, Lynch LA, et al. PRECeDe Pilot: Prevention of neonatal respiratory distress with antenatal corticosteroids before elective caesarean section in women with diabetes – a feasibility randomised trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2023. doi:10.1111/1471-0528.17513

BibTeX
@article{Said2023,
  author = {Said, Joanne M and Karahalios, Amalia and Yates, Christopher J and Kevat, Devaang A and Pszczola, Rosalynn and Lynch, Lee-Anne and Korevaar, Elizabeth and Atallah, Klea and Vasilevski, Vidanka and Sweet, Linda and Doyle, Lex W},
  title = {PRECeDe Pilot: Prevention of neonatal respiratory distress with antenatal corticosteroids before elective caesarean section in women with diabetes – a feasibility randomised trial},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2023},
  doi = {10.1111/1471-0528.17513}
}
Kostenlos starten →